PMC:1584416 / 22432-22724
Annnotations
craft-sa-dev
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3872 | 171-179 | NNS | denotes | patients |
T3873 | 180-184 | IN | denotes | with |
T3874 | 185-188 | NN | denotes | TTD |
T3875 | 189-197 | VBN | denotes | compared |
T3876 | 198-202 | IN | denotes | with |
T3877 | 203-205 | NN | denotes | wt |
T3878 | 206-214 | NNS | denotes | controls |
T3879 | 215-218 | IN | denotes | due |
T3880 | 219-221 | IN | denotes | to |
T3881 | 222-229 | VBN | denotes | reduced |
T3882 | 230-239 | NN | denotes | stability |
T3883 | 240-241 | -LRB- | denotes | [ |
T3884 | 244-246 | CD | denotes | 17 |
T3885 | 241-243 | CD | denotes | 16 |
T3886 | 243-244 | , | denotes | , |
T3887 | 246-247 | -RRB- | denotes | ] |
T3888 | 247-248 | . | denotes | . |
T3890 | 249-256 | IN | denotes | Despite |
T3892 | 257-271 | NN | denotes | overexpression |
T3893 | 272-274 | IN | denotes | of |
T3894 | 275-279 | NN | denotes | mRNA |
T3895 | 280-284 | IN | denotes | from |
T3896 | 285-288 | DT | denotes | the |
T3837 | 20-25 | NNS | denotes | cells |
T3842 | 4-7 | CC | denotes | and |
T3843 | 8-14 | NN | denotes | XpdTTD |
T3844 | 15-19 | NN | denotes | †XP |
T3845 | 14-15 | HYPH | denotes | / |
T3846 | 25-26 | . | denotes | . |
T3847 | 26-248 | sentence | denotes | Previously, using comparative immunohistochemistry, we and others have shown an up to 70% reduction of TFIIH levels in primary fibroblasts from patients with TTD compared with wt controls due to reduced stability [16,17]. |
T3848 | 27-37 | RB | denotes | Previously |
T3849 | 98-103 | VBN | denotes | shown |
T3850 | 37-39 | , | denotes | , |
T3851 | 39-44 | VBG | denotes | using |
T3852 | 45-56 | JJ | denotes | comparative |
T3853 | 57-77 | NN | denotes | immunohistochemistry |
T3854 | 77-79 | , | denotes | , |
T3855 | 79-81 | PRP | denotes | we |
T3856 | 82-85 | CC | denotes | and |
T3857 | 86-92 | NNS | denotes | others |
T3858 | 93-97 | VBP | denotes | have |
T3859 | 104-106 | DT | denotes | an |
T3860 | 117-126 | NN | denotes | reduction |
T3861 | 107-109 | IN | denotes | up |
T3862 | 113-115 | CD | denotes | 70 |
T3863 | 110-112 | IN | denotes | to |
T3864 | 115-116 | NN | denotes | % |
T3865 | 127-129 | IN | denotes | of |
T3866 | 130-135 | NN | denotes | TFIIH |
T3867 | 136-142 | NNS | denotes | levels |
T3868 | 143-145 | IN | denotes | in |
T3869 | 146-153 | JJ | denotes | primary |
T3870 | 154-165 | NNS | denotes | fibroblasts |
T3871 | 166-170 | IN | denotes | from |
R2572 | T3867 | T3865 | pobj | levels,of |
R2573 | T3868 | T3867 | prep | in,levels |
R2574 | T3869 | T3870 | amod | primary,fibroblasts |
R2575 | T3870 | T3868 | pobj | fibroblasts,in |
R2576 | T3871 | T3870 | prep | from,fibroblasts |
R2577 | T3872 | T3871 | pobj | patients,from |
R2578 | T3873 | T3872 | prep | with,patients |
R2579 | T3874 | T3873 | pobj | TTD,with |
R2580 | T3875 | T3860 | prep | compared,reduction |
R2581 | T3876 | T3875 | prep | with,compared |
R2582 | T3877 | T3878 | compound | wt,controls |
R2583 | T3878 | T3876 | pobj | controls,with |
R2584 | T3879 | T3860 | prep | due,reduction |
R2585 | T3880 | T3879 | pcomp | to,due |
R2586 | T3881 | T3882 | amod | reduced,stability |
R2587 | T3882 | T3879 | pobj | stability,due |
R2588 | T3883 | T3884 | punct | [,17 |
R2589 | T3884 | T3849 | parataxis | 17,shown |
R2590 | T3885 | T3884 | nummod | 16,17 |
R2591 | T3886 | T3884 | punct | ",",17 |
R2592 | T3887 | T3884 | punct | ],17 |
R2593 | T3888 | T3849 | punct | .,shown |
R2595 | T3892 | T3890 | pobj | overexpression,Despite |
R2596 | T3893 | T3892 | prep | of,overexpression |
R2597 | T3894 | T3893 | pobj | mRNA,of |
R2598 | T3895 | T3894 | prep | from,mRNA |
R2551 | T3843 | T3844 | compound | XpdTTD, †XP |
R2553 | T3845 | T3844 | punct | /, †XP |
R2554 | T3848 | T3849 | advmod | Previously,shown |
R2555 | T3850 | T3849 | punct | ", ",shown |
R2556 | T3851 | T3849 | advcl | using,shown |
R2557 | T3852 | T3853 | amod | comparative,immunohistochemistry |
R2558 | T3853 | T3851 | dobj | immunohistochemistry,using |
R2559 | T3854 | T3849 | punct | ", ",shown |
R2560 | T3855 | T3849 | nsubj | we,shown |
R2561 | T3856 | T3855 | cc | and,we |
R2562 | T3857 | T3855 | conj | others,we |
R2563 | T3858 | T3849 | aux | have,shown |
R2564 | T3859 | T3860 | det | an,reduction |
R2565 | T3860 | T3849 | dobj | reduction,shown |
R2566 | T3861 | T3862 | quantmod | up,70 |
R2567 | T3862 | T3864 | nummod | 70,% |
R2568 | T3863 | T3862 | quantmod | to,70 |
R2569 | T3864 | T3860 | compound | %,reduction |
R2570 | T3865 | T3860 | prep | of,reduction |
R2571 | T3866 | T3867 | compound | TFIIH,levels |
craft-ca-core-dev
Below, discontinuous spans are shown in the chain model. You can change it to the bag model.
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3125 | 8-11 | PR:000007164 | denotes | Xpd |
T3126 | 130-135 | GO:0005675 | denotes | TFIIH |
T3127 | 154-165 | CL:0000057 | denotes | fibroblasts |
T3128 | 261-271 | GO:0010467 | denotes | expression |
T3129 | 289-292 | PR:000007164 | denotes | Xpd |
craft-ca-core-ex-dev
Below, discontinuous spans are shown in the chain model. You can change it to the bag model.
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3252 | 8-11 | PR_EXT:000007164 | denotes | Xpd |
T3253 | 20-25 | CL_GO_EXT:cell | denotes | cells |
T3254 | 130-135 | GO:0005675 | denotes | TFIIH |
T3255 | 154-165 | CL:0000057 | denotes | fibroblasts |
T3256 | 203-205 | SO_EXT:wild_type_entity_or_quality | denotes | wt |
T3257 | 261-271 | GO:0010467 | denotes | expression |
T3258 | 275-279 | CHEBI_SO_EXT:mRNA | denotes | mRNA |
T3259 | 289-292 | PR_EXT:000007164 | denotes | Xpd |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
17020410-11242112-84795153 | 241-243 | 11242112 | denotes | 16 |
17020410-12393803-84795154 | 244-246 | 12393803 | denotes | 17 |
T9600 | 241-243 | 11242112 | denotes | 16 |
T46580 | 244-246 | 12393803 | denotes | 17 |